Literature DB >> 9446636

Involvement of interleukin-3 in delayed-type hypersensitivity.

N Mach1, C S Lantz, S J Galli, G Reznikoff, M Mihm, C Small, R Granstein, S Beissert, M Sadelain, R C Mulligan, G Dranoff.   

Abstract

The in vivo functions of interleukin-3 (IL-3) were investigated by generating IL-3-deficient mice. Although hematopoiesis was unimpaired in homozygous mutant animals, contact hypersensitivity reactions were compromised. IL-3 was required for efficient priming of hapten-specific contact hypersensitivity responses, but was dispensable for T-cell-dependent sensitization to tumor cells. These findings reveal a critical role for IL-3 in some forms of delayed-type hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9446636

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion.

Authors:  Tao Zou; Atsushi Satake; Priti Ojha; Taku Kambayashi
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

Review 2.  Hematopoietic stem cell: self-renewal versus differentiation.

Authors:  Jun Seita; Irving L Weissman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

3.  The zebrafish granulocyte colony-stimulating factors (Gcsfs): 2 paralogous cytokines and their roles in hematopoietic development and maintenance.

Authors:  David L Stachura; Ondrej Svoboda; Clyde A Campbell; Raquel Espín-Palazón; Ryan P Lau; Leonard I Zon; Petr Bartunek; David Traver
Journal:  Blood       Date:  2013-10-15       Impact factor: 22.113

4.  IL-3 promotes the development of experimental autoimmune encephalitis.

Authors:  Kerstin Renner; Sonja Hellerbrand; Fabian Hermann; Christine Riedhammer; Yvonne Talke; Gabriela Schiechl; Manuel Rodriguez Gomez; Simone Kutzi; Dagmar Halbritter; Nicole Goebel; Hilke Brühl; Robert Weissert; Matthias Mack
Journal:  JCI Insight       Date:  2016-10-06

5.  Transcriptome Analysis of Mycobacteria-Specific CD4+ T Cells Identified by Activation-Induced Expression of CD154.

Authors:  Shajo Kunnath-Velayudhan; Michael F Goldberg; Neeraj K Saini; Christopher T Johndrow; Tony W Ng; Alison J Johnson; Jiayong Xu; John Chan; William R Jacobs; Steven A Porcelli
Journal:  J Immunol       Date:  2017-08-18       Impact factor: 5.422

6.  Antibodies and IL-3 support helminth-induced basophil expansion.

Authors:  Tina Herbst; Julia Esser; Moira Prati; Manuel Kulagin; Rebecca Stettler; Mario M Zaiss; James P Hewitson; Patrick Merky; Joseph S Verbeek; Carole Bourquin; Mali Camberis; Melanie Prout; Rick M Maizels; Graham Le Gros; Nicola L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-28       Impact factor: 11.205

7.  Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung.

Authors:  Tim Willinger; Anthony Rongvaux; Hitoshi Takizawa; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Wojtek Auerbach; Elizabeth E Eynon; Sean Stevens; Markus G Manz; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

Review 8.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

9.  Role of GM-CSF signaling in cell-based tumor immunization.

Authors:  Shohreh Zarei; Frank Schwenter; Patricia Luy; Michel Aurrand-Lions; Philippe Morel; Manfred Kopf; Glenn Dranoff; Nicolas Mach
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

10.  Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Authors:  Thomas Enzler; Silke Gillessen; Michael Dougan; James P Allison; Donna Neuberg; Darryl A Oble; Martin Mihm; Glenn Dranoff
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.